Do selenium supplements prevent cancer?
The most reliable evidence comes from large, randomized controlled trials (RCTs) where people are randomly assigned to take selenium or a placebo. A 2018 Cochrane review, which pooled data from 10 such trials involving over 27,000 participants, found that selenium supplements had no effect on overall cancer incidence (risk ratio 0.99) or cancer mortality [3]. For specific cancers like prostate, lung, colorectal, and bladder, the results were similarly null—meaning selenium did not lower the risk [3]. This is high-certainty evidence, meaning we can be confident in the conclusion: for the general population, taking selenium supplements does not prevent cancer.
A separate 2021 Mendelian randomization study—a method that uses genetics to mimic a trial—looked at selenium levels and 22 different cancers in over 59,000 cases. It found no association between genetically predicted selenium levels and the risk of any cancer [1]. The study concluded that 'high selenium status may not prevent cancer development' [1]. This reinforces the trial findings from a different angle.
Can selenium actually promote cancer?
Yes, under certain conditions, selenium may increase cancer risk. The Selenium and Vitamin E Cancer Prevention Trial (SELECT), a massive study of over 35,000 men, found that men who took selenium supplements and had high baseline levels of vitamin E had a significantly higher risk of high-grade prostate cancer (hazard ratio 2.04) [4]. This suggests a harmful interaction between selenium and other nutrients. The same Cochrane review noted that selenium supplementation increased the risk of alopecia (hair loss), dermatitis, and type 2 diabetes, and for those with already high selenium levels, it increased the risk of high-grade prostate cancer [3]. Another analysis found a suggestive link between higher blood selenium and multiple myeloma (a blood cancer), with an odds ratio of 1.40 [1]. These findings show that selenium is not simply 'good' or 'bad'—its effect depends on dose, individual status, and other factors.
The U-shaped relationship between selenium and health is well-documented. A 2023 review explains that people with low selenium levels may benefit from supplementation, but those with adequate or high levels face potential harm, including increased cancer risk [7]. This narrow safety window means that taking extra selenium 'just in case' is risky.
Why do lab studies show selenium killing cancer cells?
Many laboratory studies—on cells in a dish or in mice—show that high doses of certain selenium compounds can kill cancer cells. For example, one study found that high-dose selenium triggered cell death in ovarian cancer cells by increasing oxidative stress [2]. Another showed that selenium nanoparticles induced apoptosis (programmed cell death) in breast cancer cells [5] and lung cancer cells [6]. These effects are real, but they occur at doses that are toxic to the whole body. The same study that showed anti-cancer effects in mice used a dose of 2000 μg/kg, while toxicity in mice started at 3000 μg/kg [2]—a very narrow margin. In humans, the Cochrane review found that selenium supplements did not reduce cancer risk, and high doses caused side effects [3]. The bottom line: what works in a petri dish does not translate to a safe, effective pill for people.
A 2021 review of selenium's anti-tumor effects notes that high doses of sodium selenite (up to 5000 μg) have been used in advanced cancer patients alongside chemotherapy and radiation, but this is a therapeutic context under medical supervision, not a prevention strategy [8]. The review emphasizes that selenium's effects are dose-dependent and that its role as a cancer treatment requires much more study.
Sources used in this answer
Selenium and cancer risk: Wide‐angled Mendelian randomization analysis
Genetically predicted selenium levels were not associated with risk of any of 22 site-specific cancers or any cancer overall, though a suggestive link to multiple myeloma (OR 1.40) and a protective trend for kidney cancer (OR 0.83) were noted.
Anti-cancer effects of high-dose selenium via lipid peroxidation in ovarian cancer.
High-dose selenium (2000 μg/kg) reduced ovarian tumor growth in mice by triggering lipid peroxidation and cell death, but toxicity occurred at 3000 μg/kg.
Selenium for preventing cancer.
In a Cochrane review of 10 RCTs (27,232 participants), selenium supplements did not reduce cancer incidence (RR 1.01) or mortality, and increased risk of high-grade prostate cancer and diabetes.
Data from Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
In the SELECT trial, men with high plasma α-tocopherol who took selenomethionine had a doubled risk of high-grade prostate cancer (HR 2.04).
Anti-breast cancer activity of biosynthesized selenium nanoparticles using Bacillus coagulans supernatant
Selenium nanoparticles synthesized from Bacillus coagulans induced 32% apoptosis in MCF-7 breast cancer cells (vs. 3% in controls) and altered apoptosis-related gene expression.
Selenium nanoparticles coated bacterial polysaccharide with potent antimicrobial and anti-lung cancer activities
Selenium nanoparticles coated with bacterial polysaccharide showed an IC50 of 5.324 μg/mL against A549 lung cancer cells and induced S-phase cell cycle arrest.
Review on the health-promoting effect of adequate selenium status
Selenium's health effects follow a U-shaped curve: deficiency increases disease risk, but excess can be harmful; supplementation benefits only those with low baseline levels.
Antitumor Effects of Selenium
High-dose sodium selenite (up to 5000 μg) has been used with chemotherapy and radiation in advanced cancer patients, but more clinical studies are needed.